Generic Frova Settlement Moving Forward Despite Endo Objections

Drug Industry Daily
A A
A federal appellate judge has ordered brand firm Endo and generics manufacturer Mylan to continue negotiating a court-mandated settlement that will allow Mylan to market a generic version of Endo’s migraine drug Frova.

To View This Article:

Login

Subscribe To Drug Industry Daily